Introduction: The objective of this study was to estimate the prevalence of dysmen-
| INTRODUC TI ON
Dysmenorrhea is the most common gynecological disorder among women of reproductive age, with a prevalence ranging between 45% and 95%. 1, 2 Primary dysmenorrhea, painful menstruation without pelvic abnormalities, may be associated with vomiting, fatigue, back pain, headache, dizziness, sleeplessness and diarrhea. 3 Although there are differences in definition, between 10% and 42% suffer from dysmenorrhea categorized as severe, [4] [5] [6] which could be a symptom of secondary dysmenorrhea such as endometriosis or other pelvic pathology.
In a normal ovulatory menstrual cycle, fatty acids, particularly arachidonic acids, are released after the withdrawal of progesterone prior to menstruation. This initiates a cascade of leukotrienes and prostaglandins (PG) in the uterus, causing an inflammatory response resulting in cramps and systemic symptoms. 3 In particular, the PG-F2α, cyclooxygenase (COX) metabolite of arachidonic acid, causes potent vasoconstriction and myometrial contractions, leading to hypercontractility of the uterus, ischemia and pain. 7 The severity of symptoms is considered directly proportional to the amount of PG released. 7, 8 However, there are women with dysmenorrhea showing non-elevated levels of PG-F2α, 9 suggesting the etiology not being completely understood. Several studies suggest that dysmenorrhoic women have a hypersensitization of pain fibers, 10, 11 leading to dysmenorrhea being classified as a Chronic pain syndrome.
12
Dysmenorrhea is the leading cause of short-term school absenteeism. 13 Previous studies have also shown negative effects on academic and social performances as well as a sub-therapeutic level of self-treatment of these recurring pains among adolescents. 14, 15 It is also known that there is a low tendency to seek medical advice for this condition, 6 maybe due to the perception of dysmenorrhea being a normal condition rather than a disorder.
Severe dysmenorrhea can be a sign of endometriosis, 16 ,17 a chronic progressive disease due to ectopic location of endometrium which causes cyclic and acyclic pelvic pain as well as symptoms from the intestinal and urinary tract.
COX-inhibitors constitute the most common treatment compound for pain from dysmenorrhea. By inhibiting endometrial PG production COX-inhibitors can also reduce menstrual blood loss.
18
Hormonal contraceptive methods limit endometrial growth and reduce the amount of endometrial tissue available for PG and leukotriene production, and those methods that inhibit ovulation also reduce progesterone secretion.
The aim of this study was to identify the prevalence of dysmenorrhea among adolescents in Stockholm. We also wanted to explore the negative effects on social and academic performance and how the disability due to dysmenorrhea was managed.
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| RE SULTS
Mean time to complete the questionnaire was 5 minutes 20 seconds. Most women, 61%, used a computer and 39% used a mobile phone or tablet.
| Characteristics of the study population
Of the 3998 young women invited to participate, 1785 (45%) answered the survey. The mean age was 16.2 years.
Nine percent of the participants were smokers and 31% reported having experienced sexual intercourse. Fourteen respondents (0.8%) had not yet had menarche and three (0.2%) did not want to answer whether they had. Mean age for menarche was 12.4 years and mean duration of bleeding among the participants was 5 days.
| Dysmenorrhea
Dysmenorrhea was reported by 1580 of the 1785 women (89%, 95%
CI 87-90) as shown in Figure 1 . Those that did not have dysmenorrhea,
were pre-menarche or were uncertain, did not have to answer any further questions. Those who failed to answer were excluded.
The severity of dysmenorrhea is shown in Figure 2 .
| Other menstrual-related symptoms
Symptoms such as acyclic abdominal pain, fatigue and headache were more commonly experienced than syncope, vomiting, dysuria or dyschezia, which were reported to a lesser extent (Table 1) .
| Healthcare visits and analgesics
Contact with healthcare was reported by 33% (525/1580, 95% CI 31-36), mostly with school nurses and midwives at youth clinics.
There was a consultation with a doctor in 7% (116/1580, 95% CI 6-9).
Among women with acyclic abdominal pain, 78 had a suggested diagnosis by a physician such as irritable bowel syndrome, dyspepsia/ gastritis, lactose intolerance, stress/anxiety and celiac disease.
Pain killers, mostly COX-inhibitors and or paracetamol/acetaminophens, were used by 80% (1265/1580, 95% CI 78-82), the most popular being ibuprofen, used by 824, followed by acetaminophen, used by 738 (Table 2 ). Both are available in low concentrations over the counter without a prescription.
However, 63% (997/1580, 95% CI 61-65) reported suffering from pain that could not be relieved with analgesics. Combining acetaminophen and COX-inhibitors was reported by 189, but only 465 responded to that question. The use of opioids, codeine, was stated by 0.2% (2/1265).
| Hormonal therapy/contraceptives
Twenty percent (313/1580, 95% CI 18-22) stated that they used hormonal therapy. An oral contraceptive pill was the dominant hormo- 
| Bias analyses
The high prevalence of dysmenorrhea in our study could present a selection bias if girls with menstrual problems were more prone to respond to the survey. If hypothetically all the non-respondents were pain-free, the prevalence of dysmenorrhea would be 40%
(1580/3998), 23% (932/3998) would be absent from social activities due to dysmenorrhea and 24% (954/3998) would be absent from school a few times per year or more due to dysmenorrhea. 
| D ISCUSS I ON
Our findings demonstrate that dysmenorrhea has a large impact on the lives of many adolescents in Stockholm. As many as 89% of our study cohort suffered from monthly pain and 36% of these young women reported severe pain. In addition to menstrual pain, extragenital symptoms were also quite prevalent among our participants, eg headache, fatigue, dysuria and dyschezia. Approximately twothirds of the young women reported absenteeism from school as well as from leisure activities and they experienced a negative effect on test results due to dysmenorrhea several times per year.
In comparison with similar studies made in Australia and Finland (Table 3 ) our study shows a surprisingly high rate of monthly absenteeism due to pain and a very low tendency to seek consultation with a doctor. Many respondents had consulted school nurses and midwives, but they cannot prescribe analgesics or hormonal treatment for menstrual pain. The Australian study 19 showed that a higher rate of consultations with doctors did not lead to a higher rate of use of oral contraceptives compared with the other two studies.
The group of respondents reporting monthly absenteeism (n = 228) in our study had a higher mean NRS (8.75) than the total group (6.34) and had sought medical advice by a doctor to a greater extent (21% compared with 7%), which implies a disabling condition rather than a sign of social acceptance. Only 21% (48/228) in this group used hormones to treat dysmenorrhea.
In addition to physical, psychological and social suffering this condition might have long-term negative economic impacts for the individual as well as for society.
Systemic symptoms of dysmenorrhea such as vomiting, syncope, fatigue and headaches can be quite disabling. This is also true for heavy bleeding, as 71% bled through their clothes and 38% needed double protection more than a few times per year (data not shown).
These experiences and precautions can lead to embarrassment and stigma.
Adolescents fail to self-medicate adequately, which reflects the lack of awareness regarding the optimal use of analgesics. The reported intake of pain medication (Table 2) suggests suboptimal dosage of acetaminophens; the majority reported an intake of half of the recommended dosage of 1 g, and 41% reported repeating the dose.
Those taking 400 mg ibuprofen tended to repeat the dose in only 49% of the cases. The majority reported taking one tablet regardless of substance or concentration (69% for acetaminophen, 83% for ibuprofen).
Many of the young women in our study present possible early signs of endometriosis such as acyclic abdominal pain (44%), dyschezia (37%), severe dysmenorrhea (36%) and dysuria (35%). Six percent reported inadequate effect of analgesics and severe dysmenorrhea despite the use of oral contraceptives, possibly indicating endometriosis, the same TA B L E 2 The most commonly used analgesics presented by dose and number of tablets per intake Two girls had been diagnosed with endometriosis (NRS 10 and 9, respectively); both were taking oral contraceptives and stated that they were absent from school every month and experienced insufficient effect from analgesics. A third respondent with NRS10 stated she probably had endometriosis, but her doctor did not want to perform surgery before confirmation of diagnosis.
In a study from Gothenburg, Sweden, published in 1982, 4 it was demonstrated that absenteeism from work or school occurred with a prevalence of 51% occasionally and 8% monthly which unfortunately indicates no improvement in Sweden during these last 35 years. The tendency to get medical attention from a doctor has dropped from 22% to 7%, which could be a sign of normalization of disabling dysmenorrhea.
In our study the response rate was high, 45%, as well as the number of participants (n = 1785). The survey was performed in an urban setting and thus the results may not be applicable to other areas, which is a limitation. Another factor that could influence our findings is that the survey was conducted in Swedish, which may have excluded some respondents. Selection may bias effect estimates in cohort studies; 20 however, sensitivity analyses suggested that even if there was selection bias, and even if we overestimated the problem based on the actual data, the proportion of suffering teenagers would still be high and a matter of public health concern.
Despite possible limitations in our methods, the present findings call for raised awareness and education among teen- 
| CON CLUS ION
There is a need for more research to increase the options for treating primary and secondary dysmenorrhea. The options within analgesics are too few for the girls who for some reason cannot take COX-inhibitors, and to prescribe opiates to young people cannot be recommended. The suggestion of hormonal therapy can be met with resistance from the young women, their parents and sometimes also by healthcare workers. Our findings indicate that many young women are disabled in their daily life because of dysmenorrhea.
CO N FLI C T O F I NTE R E S T
L.M. is a member of an advisory board for BayerPharma AG Berlin.
M.E. is Medical Director at ViforPharma Nordiska AB. L.S. has no conflict of interest. TA B L E 3 Comparison with similar studies
ORCID

Lisa
